Effectiveness of ceftazidime–avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia

Update on the role of ceftazidime-avibactam in the management of carbapenemase-producing Enterobacterales

(2020) Beatriz Dietl et al.   Future Microbiology

Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance

(2020) Jeffrey R Strich et al.   JOURNAL OF INFECTIOUS DISEASES

Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study

(2019) Andrew J Stewardson et al.   LANCET INFECTIOUS DISEASES

Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae

(2018) Mario Tumbarello et al.   CLINICAL INFECTIOUS DISEASES

Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections

(2018) Matt Shirley   DRUGS

Clinical Pharmacokinetics and Pharmacodynamics of Ceftazidime–Avibactam Combination: A Model-Informed Strategy for its Clinical Development

(2018) Sherwin K. B. Sy et al.   CLINICAL PHARMACOKINETICS

Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility

(2018) J. Lellouche et al.   CLINICAL MICROBIOLOGY AND INFECTION

CLINICAL CHARACTERISTICS AND PROGNOSIS OF INFECTIONS CAUSED BY OXA-48 CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE IN PATIENTS TREATED WITH CEFTAZIDIME-AVIBACTAM

(2018) C. De la Calle et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients

(2017) Juan J. Castón et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

(2017) Belén Gutiérrez-Gutiérrez et al.   LANCET INFECTIOUS DISEASES

Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program

(2016) Elizabeth Temkin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations

(2016) David van Duin et al.   CLINICAL INFECTIOUS DISEASES

A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae

(2016) Belén Gutiérrez-Gutiérrez et al.   MAYO CLINIC PROCEEDINGS

Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae

(2016) Elizabeth A. Neuner et al.   Virulence

Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli

(2015) Gabrielle A. Gibson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections

(2015) H. J. Morrill et al.   Open Forum Infectious Diseases

Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival

(2014) Ilker Inanç Balkan et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES